<DOC>
	<DOCNO>NCT00922025</DOCNO>
	<brief_summary>The objective investigate correlation smoking pattern clinical efficacy EGFR TKIs male patient locally advanced metastasize non-small cell lung cancer adeno histology fail 1st line chemotherapy . Health care resource usage , quality life ( EQ-5D ) practice EGFR mutation test also evaluate . Current practice EGFR mutation test Taiwan survey .</brief_summary>
	<brief_title>Multicentre Study Explore Correlation Between Smoking Pattern Clinical Efficacy Epidermal Growth Factor Receptor ( EGFR ) Tyrosine Kinase Inhibitor ( TKI ) Male Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Male patient age 20 year old Histological cytological confirmation NSCLC adeno histology . If sputum available sample , second positive test necessary cytological confirmation Locally advance metastatic firstline chemotherapy . Imaging evidence disease progression either chest X ray , CT MRI assessment measurable lesion . If measurable lesion available , evaluable lesion acceptable</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>Male</keyword>
	<keyword>Smoking Pattern</keyword>
	<keyword>Efficacy</keyword>
</DOC>